Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Other Operating Expenses (2016 - 2025)

OptimizeRx's Other Operating Expenses history spans 16 years, with the latest figure at $1.1 million for Q3 2025.

  • For Q3 2025, Other Operating Expenses fell 87.42% year-over-year to $1.1 million; the TTM value through Sep 2025 reached $21.6 million, up 79.32%, while the annual FY2024 figure was $23.2 million, 1181.89% up from the prior year.
  • Other Operating Expenses for Q3 2025 was $1.1 million at OptimizeRx, up from $1.1 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $18.4 million in Q4 2024 and bottomed at -$7.1 million in Q4 2021.
  • The 5-year median for Other Operating Expenses is $1.1 million (2024), against an average of $3.2 million.
  • The largest annual shift saw Other Operating Expenses crashed 198.53% in 2021 before it surged 1737.9% in 2024.
  • A 5-year view of Other Operating Expenses shows it stood at -$7.1 million in 2021, then skyrocketed by 326.9% to $16.2 million in 2022, then plummeted by 91.72% to $1.3 million in 2023, then surged by 1270.27% to $18.4 million in 2024, then tumbled by 94.13% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for OPRX's Other Operating Expenses are $1.1 million (Q3 2025), $1.1 million (Q2 2025), and $1.1 million (Q1 2025).